#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis membranoproliferative Lymphangiosarcoma Ischaemic stroke Renal cancer metastatic Prophylaxis against transplant rejection Inflammatory myofibroblastic tumour Follicular lymphoma Adenocarcinoma gastric Thyroid cancer metastatic Focal segmental glomerulosclerosis Wolfram syndrome Autoinflammation with infantile enterocolitis Hypochondroplasia Stiff person syndrome Polycythaemia vera More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Basic Information Marfan’s syndrome – Trials in Disease Thrombotic thrombocytopenic purpura – Trials in Disease Primary hyperoxaluria – Basic Information Nephrotic syndrome – Life with Disease Haemophilia A without inhibitors – Treatment Alport’s syndrome – Life with Disease Chondrosarcoma metastatic – Trials in Disease Myxofibrosarcoma Factor VIII deficiency – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate TRONTINEMAB Hydrocortisone Ph. Eur. Valoctocogene Roxaparvovec Permethrin Lumasiran Sibeprenlimab Enalapril Maleate CHLOROQUINE PHOSPHATE Fludarabine Phosphate Ph. Eur. ROPINIROLE Odm-208 Landiolol Hydrochloride Heterodimeric Interleukin-15 Midazolam CHLORMADINONE ACETATE Alemtuzumab Dexamethasone Isonicotinate Oditrasertib MARALIXIBAT More therapies…

    Learn about Your Condition

    Intellectual disability Endometrial stromal sarcoma Hypomagnesaemia Meningioma Dupuytren's contracture Eosinophilic gastritis B-cell lymphoma recurrent Peritoneal cancer index Intermittent claudication Congenital myopathy HER2 positive breast cancer Renal cancer stage IV Small intestine carcinoma Retroperitoneal cancer Axial spondyloarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study comparing CHF 5993 (beclometasone/formoterol/glycopyrronium) to fluticasone/salmeterol inhalation in adolescents with uncontrolled asthma on medium-dose inhaled therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Salmeterol
    • Fluticasone Propionate
    Germany Italy Spain
  • Comparison of compression therapy alone versus compression therapy with phenoxymethylpenicillin for preventing recurrent erysipelas in lower limbs

    Not yet recruiting

    3 1 1 1
    France
  • Study of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Bedaquiline
    • Clofazimine
    • Linezolid
    France
  • Study of transdermal testosterone gel to improve ovarian response in women with low ovarian reserve and androgen receptor polymorphism undergoing fertility treatment

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Follitropin Alfa
    • Ganirelix
    • Testosterone
    Spain
  • Study of dornase alfa and cisplatin treatment for patients with refractory germ cell cancer

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Dornase Alfa
    • Cisplatin
    Slovakia
  • Study of Ferumoxtran-10 Enhanced MRI for Detecting Lymph Node Metastases in Patients with Esophageal Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • FERUMOXTRAN-10
    The Netherlands
Previous Page
1 … 768 769 770 771 772 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!